Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 55, Issue 40, Pages 12372-12375
Publisher
Wiley
Online
2016-09-07
DOI
10.1002/anie.201605058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Versatile Approach Towards Nucleobase-Modified Aptamers
- (2015) Fabian Tolle et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Evolution of Functional Six-Nucleotide DNA
- (2015) Liqin Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aptamers from Cell-Based Selection for Bioanalytical Applications
- (2013) Weihong Tan et al. CHEMICAL REVIEWS
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- Glypican-3 antibodies: A new therapeutic target for liver cancer
- (2013) Mingqian Feng et al. FEBS LETTERS
- Generation of high-affinity DNA aptamers using an expanded genetic alphabet
- (2013) Michiko Kimoto et al. NATURE BIOTECHNOLOGY
- In vitro selection with artificial expanded genetic information systems
- (2013) K. Sefah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amplification, Mutation, and Sequencing of a Six-Letter Synthetic Genetic System
- (2011) Zunyi Yang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
- (2011) Stephan Kraemer et al. PLoS One
- Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
- (2010) Kiyotaka Nakano et al. ANTI-CANCER DRUGS
- Synthetic biology, tinkering biology, and artificial biology. What are we learning?
- (2010) Steven A. Benner et al. COMPTES RENDUS CHIMIE
- Glypican-3: A new target for cancer immunotherapy
- (2010) Mitchell Ho et al. EUROPEAN JOURNAL OF CANCER
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Expanded Genetic Alphabets in the Polymerase Chain Reaction
- (2009) Zunyi Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Overgrowth of a mouse model of Simpson– Golabi–Behmel syndrome is partly mediated by Indian Hedgehog
- (2009) Mariana I Capurro et al. EMBO REPORTS
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding
- (2008) Mariana I. Capurro et al. DEVELOPMENTAL CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started